Sunday, December 1, 2019

Genetic Testing for APOL1 Genetic Variants in Clinical Practice: Finally Starting to Arrive. - PubMed - NCBI

Genetic Testing for APOL1 Genetic Variants in Clinical Practice: Finally Starting to Arrive. - PubMed - NCBI

 2019 Nov 18. pii: CJN.01810219. doi: 10.2215/CJN.01810219. [Epub ahead of print]

Genetic Testing for APOL1 Genetic Variants in Clinical Practice: Finally Starting to Arrive.

Author information


1
Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases and Basic Research Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and jbkopp@nih.gov.
2
Basic Research Program Frederick National Laboratories for Cancer Research, Frederick, Maryland.

KEYWORDS:

end stage kidney disease; genetic testing; genetic variants; genetic variation; kidney disease

PMID:
 
31740572
 
DOI:
 
10.2215/CJN.01810219

No comments:

Post a Comment